Nanobiotechnology Advances in Oncology

Abstract

Abbreviations3HM= 3-helix micelles; BBB= Blood Brain Barrier; BPB= Brain Abstract Nanobiotechnology advances in cancer treatment are discussed including detailed consideration of the several drugladen nanoparticles and the nanocarriers used to deliver them at cancerous sites. This burgeoning field is contrasted with conventional chemotherapy and its clinical advantages set forth. New directions for improving the technology are also charted, but caution is noted regarding its potential toxic effects and the correspondingly associated need for more studies.